Covista (CVSA)
NYSE:CVSA
Want to see CVSA full AI Analyst Report?
CVSA Stock Chart & Stats
$117.91
-$0.04(-0.04%)
At close: 4:00 PM EST
$117.91
-$0.04(-0.04%)
Day’s Range― - ―
52-Week Range$86.97 - $156.26
Previous CloseN/A
VolumeN/A
Average Volume (3M)330.98K
Market Cap
$3.96B
Enterprise Value$4.63B
Total Cash (Recent Filing)$56.28M
Total Debt (Recent Filing)$729.55M
Price to Earnings (P/E)12.3
Beta0.61
Next Earnings
May 07, 2026EPS Estimate
1.72Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)2.43
Shares Outstanding34,508,522
10 Day Avg. Volume266,711
30 Day Avg. Volume330,976
Financial Highlights & Ratios
PEG Ratio0.25
Price to Book (P/B)3.29
Price to Sales (P/S)2.64
P/FCF Ratio16.41
Enterprise Value/Market Cap1.17
Enterprise Value/Revenue2.45
Enterprise Value/Gross Profit4.27
Enterprise Value/Ebitda10.79
Forecast
1Y Price Target
$153.75Price Target Upside30.40% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
EPS Forecast (FY)7.91
Revenue Forecast (FY)$1.92B
Bulls Say, Bears Say
Bulls Say
AI-enabled Student LifecycleDeployment of AI across the student lifecycle, including AI-assisted enrollment, predictive analytics, persistence-enhancing micro-grants, and an AI tutor integrated into coursework, could boost enrollment conversion and student retention while differentiating the learning experience.
Financing Access And Marketing EfficiencyExisting financing partnerships that increase student access to funding, together with noted improvements in marketing efficiency and enrollment funnel conversion at key brands, can reduce barriers to enrollment and support revenue growth.
Healthcare Program Focus And Employer IntegrationStrategic emphasis on nursing, medical and veterinary programs combined with employer integration initiatives that build contracted pipelines to healthcare systems can strengthen placement outcomes and capture demand driven by workforce shortages.
Bears Say
Aggressive Risk Profile And Investor VolatilityAnalyst classification of the company's suitability as aggressive signals higher investment risk and the potential for greater share-price volatility and downside during operational setbacks.
Brand Performance Concentration RiskUneven performance across brands, where stronger results at one brand have been needed to offset weakness at another, raises reliance on a subset of programs and increases volatility in consolidated results.
Enrollment Funnel Weakness At A Major BrandEnrollment funnel challenges and slowing trends at a major brand, including declines in some post-licensure nursing programs, could weigh on near-term enrollment and revenue performance.
Covista News
CVSA FAQ
What was Covista’s price range in the past 12 months?
Covista lowest stock price was $86.97 and its highest was $156.26 in the past 12 months.
What is Covista’s market cap?
Covista’s market cap is $3.96B.
When is Covista’s upcoming earnings report date?
Covista’s upcoming earnings report date is May 07, 2026 which is in 6 days.
How were Covista’s earnings last quarter?
Covista released its earnings results on Jan 28, 2026. The company reported $2.43 earnings per share for the quarter, beating the consensus estimate of $2.188 by $0.242.
Is Covista overvalued?
According to Wall Street analysts Covista’s price is currently Undervalued.
Does Covista pay dividends?
Covista pays a Semiannually dividend of $0.18 which represents an annual dividend yield of N/A. See more information on Covista dividends here
What is Covista’s EPS estimate?
Covista’s EPS estimate is 1.72.
How many shares outstanding does Covista have?
Covista has 34,508,522 shares outstanding.
What happened to Covista’s price movement after its last earnings report?
Covista reported an EPS of $2.43 in its last earnings report, beating expectations of $2.188. Following the earnings report the stock price went down -7.022%.
Which hedge fund is a major shareholder of Covista?
Currently, no hedge funds are holding shares in CVSA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Covista Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$153.75 (30.40% Upside)
$153.75 (30.40% Upside)
Blogger Sentiment
Bullish
CVSA Sentiment 80%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 307.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $3.8M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Positive
Last 7 Days ▲ 0.4%
Last 30 Days ▲ 2.0%
Last 30 Days ▲ 2.0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
11.19%
12-Months-Change
Fundamentals
Return on Equity
17.76%
Trailing 12-Months
Asset Growth
-3.98%
Trailing 12-Months
Company Description
Covista
Adtalem Global Education, Inc. engages in the provision of post-secondary education. It operates through the following segments: Chamberlain, Walden, and Medical and Veterinary. The Chamberlain segment offers degree and non-degree programs in the nursing and health professions postsecondary education industry. The Walden segment covers online certificates, bachelor's, master's, and doctoral degrees, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. The Medical and Veterinary segment includes degree and non-degree programs in the medical and veterinary postsecondary education industry. The company was founded by Dennis J. Keller and Ronald L. Taylor in 1973 and is headquartered in Chicago, IL.
CVSA Company Deck
CVSA Earnings Call
Q2 2026
0:00 / 0:00
CVSA Stock 12 Month Forecast
Average Price Target
$153.75
▲(30.40% Upside)
Technical Analysis
Perdoceo Education
―
Grand Canyon Education
―
Strategic Education
―
Graham Holdings
―
Laureate Education
―
Ownership Overview
2.83% Insiders
38.20% Mutual Funds
0.87% Other Institutional Investors
31.58% Public Companies and Individual Investors